Delivery Order SPE2DB22D1202-SPE2DB24FUTZ2
Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $2.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Doxepin HCL 3 MG Tablets in packages of 30. The $1,795.44 contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous federal contracts from DLA to supply pharmaceuticals and medical supplies for military treatment programs and facilities....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,893,338 tablets of 3 mg Doxepin HCL. The $1,712.17 contract has a completion date of March 8, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor and does not have any major subcontractors listed. This delivery order falls under an indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Doxepin HCL 3 mg tablets. The contract has a ceiling value of $2,467.05 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,858,367 units of Doxepin HCL 6 mg tablets. The $2,959.14 contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is an experienced prime contractor that holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,336.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,296,828 units of Doxepin HCL 3 mg tablets. This fixed-price delivery order has an ultimate completion date of April 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,459.58 firm fixed price contract is for the supply of 4,563,927,917 units of doxepin hydrochloride 6 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 and a performance period...
- This federal contract award, valued at $3,661.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,855,860 units of Doxepin Hydrochloride 6 mg tablets, with a period of performance through January 8, 2025. The contract is a firm fixed-price arrangement and was not set aside for any specific business category. Amerisourcebergen holds a significant...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $6,829.72 order is for the supply of 3 mg doxepin hydrochloride tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
- This federal contract award is for the delivery of 4,563,032,807 units of Doxepin HCL 3 mg Tablets in 30-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The fixed-price delivery order has a ceiling value of $5,222.26 and a completion date of December 8, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Doxepin HCL 3 mg tablets in 30-count packages, with a ceiling value of $1,751.01 and a completion date of March 29, 2024. The contract is a firm fixed price delivery order, which is part of a larger indefinite delivery contract...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUTZ2Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,982,912 units of the 3 mg doxepin hydrochloride tablet, a specialty pharmaceutical product. The $2,493.30 contract has a completion date of March 18, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp, the prime contractor, is also the holder of a $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. No major subcontractors were indicated in the provided information.
Generated 6/14/24, 10:09 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 3/15/24 |